This is a China news story, published by Yahoo, that relates primarily to The U.S. Food and Drug Administration news.
For more China news, you can click here:
more China newsFor more drug discoveries news, you can click here:
more drug discoveries newsFor more news from Yahoo, you can click here:
more news from YahooOtherweb, Inc is a public benefit corporation, dedicated to improving the quality of news people consume. We are non-partisan, junk-free, and ad-free. We use artificial intelligence (AI) to remove junk from your news feed, and allow you to select the best health news, business news, entertainment news, and much more. If you like drug discoveries news, you might also like this article about
experimental cancer drug. We are dedicated to bringing you the highest-quality news, junk-free and ad-free, about your favorite topics. Please come every day to read the latest cancer drug development news, conventional chemotherapy news, drug discoveries news, and other high-quality news about any topic that interests you. We are working hard to create the best news aggregator on the web, and to put you in control of your news feed - whether you choose to read the latest news through our website, our news app, or our daily newsletter - all free!
cancer drugsReuters
•81% Informative
The U.S. Food and Drug Administration has placed a partial clinical hold on an early-stage study of its experimental cancer drug.
The drug, an antibody-drug conjugate (ADC), was being studied in a trial sponsored by China -based MediLink .
ADCs are designed to target only cancer cells, unlike conventional chemotherapy, potentially reducing damage to normal cells.
VR Score
91
Informative language
97
Neutral language
77
Article tone
formal
Language
English
Language complexity
62
Offensive language
not offensive
Hate speech
not hateful
Attention-grabbing headline
not detected
Known propaganda techniques
not detected
Time-value
short-lived
External references
no external sources
Source diversity
no sources
Affiliate links
no affiliate links